display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positivebreast cancer - triple negative
la/mBC - HR-positive - 1st line (L1)mBC - Triple negative (TNBC) - 1st Line (L1)mBC - TNBC - L1 - all population
capivasertib plus paclitaxel BEECH PAKT ... PAKT ...

Study type: